Corient Capital Partners’s Synopsys SNPS Stock Holding History
Bought
Maintained
Sold
Other funds holding SNPS
PAMS
Corient Capital Partners's SNPS Position: Q3 2022 in Review
Corient Capital Partners increased its Synopsys (SNPS) stake by 11% in Q3 2022, buying an estimated $147K and bringing the position to 4,466 shares worth $1.36M. The position accounts for 0.1% of the portfolio, ranked #168.
Corient Capital Partners first reported a position in SNPS in Q2 2019 and has held it in 14 quarters since. 878 funds tracked by Wall St. Rank hold SNPS as of Q3 2022.
- Corient Capital Partners held 4,466 shares of Synopsys worth $1.36M as of Q3 2022.
- Corient Capital Partners bought 433 Synopsys shares in Q3 2022, an estimated $147K.
- Synopsys made up 0.1% of Corient Capital Partners's portfolio in Q3 2022, its #168 holding.
- Corient Capital Partners first reported a position in Synopsys in Q2 2019 and has held it in 14 quarters since.
- 878 funds tracked by Wall St. Rank held Synopsys as of Q3 2022.
Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.